Proresolving Lipid Mediators Restore Balance to the Vulnerable Plaque

Circulation Research

Volumn 119, Issue 9, 2016, Pages 972-974

  Thorp, Edward B ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

acute coronary syndrome; apolipoprotein; atherosclerosis; cataloging; Editorials; risk factors

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CD59 ANTIGEN; COLLAGEN; DOCOSAHEXAENOIC ACID; LEUKOTRIENE B4; LIPID; LIPOXIN; MARESIN; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; RESOLVIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BIOSYNTHESIS; DISEASE COURSE; HUMAN; INFLAMMATION; INFLAMMATORY CELL; INTRACELLULAR SIGNALING; LIPID DEGRADATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SMOOTH MUSCLE CELL; CORONARY ARTERY DISEASE;

ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; HUMANS; LIPIDS; PLAQUE, ATHEROSCLEROTIC;

EID: 84992096718     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.309794     Document Type: Review

References (14)

1. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32:2045-2051. doi: 10.1161/ATVBAHA.108.179705
2. Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 1995;15:551-561
3. Brezinski DA, Nesto RW, Serhan CN. Angioplasty triggers intracoronary leukotrienes and lipoxin A4. Impact of aspirin therapy. Circulation. 1992;86:56-63
4. Buckley CD, Gilroy DW, Serhan CN. Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity. 2014;40:315-327. doi: 10.1016/j.immuni.2014.02.009
5. Ho KJ, Spite M, Owens CD, Lancero H, Kroemer AH, Pande R, Creager MA, Serhan CN, Conte MS. Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis. Am J Pathol. 2010;177:2116-2123. doi: 10.2353/ ajpath.2010.091082
6. Merched AJ, Ko K, Gotlinger KH, Serhan CN, Chan L. Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J. 2008;22:3595-3606. doi: 10.1096/fj.08-112201
7. Dwyer JH, Allayee H, Dwyer KM, Fan J, Wu H, Mar R, Lusis AJ, Mehrabian M. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med. 2004;350:29-37. doi: 10.1056/NEJMoa025079
8. Viola JR, Lemnitzer P, Jansen Y, Csaba G, Winter C, Neideck C, Silvestre-Roig C, Dittmar G, Döring Y, Drechsler M, Weber C, Zimmer R, Cenac N, Soehnlein O. Resolving lipid mediators maresin 1 and resolvin D2 prevent atheroprogression in mice. Circ. Res. 2016;119:1030-1038. doi: 10.1161/CIRCRESAHA.116.309492
9. Drechsler M, de Jong R, Rossaint J, Viola JR, Leoni G, Wang JM, Grommes J, Hinkel R, Kupatt C, Weber C, Döring Y, Zarbock A, Soehnlein O. Annexin A1 counteracts chemokine-induced arterial myeloid cell recruitment. Circ Res. 2015;116:827-835. doi: 10.1161/ CIRCRESAHA.116.305825
10. Fredman G, Kamaly N, Spolitu S, Milton J, Ghorpade D, Chiasson R, Kuriakose G, Perretti M, Farokhzad O, Farokzhad O, Tabas I. Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice. Sci Transl Med. 2015;7:275ra20. doi: 10.1126/scitranslmed.aaa1065
11. Hasturk H, Abdallah R, Kantarci A, Nguyen D, Giordano N, Hamilton J, Van Dyke TE. Resolvin E1 (RvE1) attenuates atherosclerotic plaque formation in diet and inflammation-induced atherogenesis. Arterioscler Thromb Vasc Biol. 2015;35:1123-1133. doi: 10.1161/ATVBAHA.115.305324
12. Fredman G, Hellmann J, Proto J, Kuriakose G, Colas RA, Dorweiler B, Connolly ES, Solomon R, Jones DM, Heyer EJ, Spite M, Tabas I. An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques. Nature Commun. 2016;7:12859. doi: 10.1038/ncomms12859
13. Cai B, Thorp EB, Doran AC, Subramanian M, Sansbury BE, Lin CS, Spite M, Fredman G, Tabas I. MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation. Proc Natl Acad Sci U S A. 2016;113:6526-6531. doi: 10.1073/ pnas.1524292113
14. Merched AJ, Serhan CN, Chan L. Nutrigenetic disruption of inflammation-resolution homeostasis and atherogenesis. J Nutrigenet Nutrigenomics. 2011;4:12-24. doi: 10.1159/000326890